Depression, Anxiety and Sleep Disturbances in Patients with Craniocervical Dystonias
Objective: This study aimed to examine whether botulinum neurotoxin (BT) treatment affects nonmotor symptoms of dystonia, particularly depression (D), anxiety (A) and sleep disturbances (SD)…Domain-specific impact of mood/anxiety disorders on quality of life in idiopathic dystonia
Objective: To evaluate the relationship between mood/anxiety disorder severity and quality of life (QoL) domains in adult-onset idiopathic dystonia (AOID). Background: Depression and anxiety exert…Depression and anxiety in cervical dystonia
Objective: We had proposed to evaluate appearance of anxiety and depression in patients with cervical dystonia(CD) and influence of disease on the quality of life.…Health-related quality of life in cervical dystonia; the hidden and unaddressed effect of anxiety
Objective: The aim of this study was to assess health-related quality of life in patients with cervical dystonia and assess factors considered to contribute to…Predictive Factors for Depression in a Multicentric Parkinson’s Disease Mexican Cohort
Objective: To identify predictive factors for depression in a multicentric Parkinson’s disease (PD) mexican cohort. Background: Depression is a common symptom of PD with a…Trust the Patient’s Report, not the Doctor’s: Non-Motor Symptoms and Quality of Life in Cervical Dystonia
Objective: To assess the prevalence of mood disorder and measure health-related quality of life (Hr-QoL) in relation to, pain, disability and disease severity in cervical…Clinical and cognitive features of anxiety in Parkinson’s disease
Objective: To determine the demographic, clinical and cognitive features associated with anxiety disorders in Parkinson’s disease (PD). Background: The point prevalence of anxiety disorders in…Deep phenotyping adult onset isolated cervical dystonia; the importance of symptomatic anxiety and depression.
Objective: Objective:We aimed to characterise the demographic and clinical aspects of cervical dystonia (CD) patients with symptomatic anxiety and depression. We hypothesised that these patients…Neuropsychiatric manifestations in Parkinson’s disease
Objective: Evaluate the different neuropsychiatric manifestations in Parkinson's disease. Background: Parkinson's disease (PD) is the second most common neurodegenerative pathology after Alzheimer's disease, although PD…Mindfulness Training to Reduce Anxiety in Parkinson’s Disease: A Cautionary Tale about Wearable Technology
Objective: This study aimed to determine the feasibility of using a non-pharmacologic intervention (mindfulness training; MT) administered with a wearable tracker to alleviate anxiety through…
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- …
- 17
- Next Page »